HOME >> MEDICINE >> NEWS
New therapeutic targets for neurodegenerative diseases

The focus of work in the Neurosciences Departments Neurobiology Laboratory at the University of the Basque Countrys Faculty of Medicine and Odontology is the investigation of the molecular and cellular bases of neurodegenerative illnesses those that affect the brain and the spinal cord. Some of these neurodegenerative illnesses are well known and affect a significant part of the population, such as Alzheimers disease and multiple sclerosis.

Researchers at the University of the Basque Country (UPV-EHU) are studying the signals in the central nervous system - the brain and the spinal cord - that do not function well, in particular, those signals that cause the death of nerve cells. There are basically two types of cells in the central nervous system: neurones and the glial cells. Both types are sensitive to these functioning errors and both can die. In the case of Alzheimers disease, it is the neurones, above all, that die. However, in the case of multiple sclerosis, it is a class of glial cells known as oligodendrocytes that perish.

From in vitro cells to biological samples of human origin

The researchers at the Neurobiology Laboratory are investigating cells in cultures - neurones, oligodendrocytes or other cells of the nervous system -, and are trying to reproduce in vitro circumstances that are thought to be relevant in these ailments. That is to say, they are creating the conditions that cause the death of these cells, in order to determine what molecules intervene in the process from the moment of the lethal signal to the point where the cells collapse. In this type of experimental work a series of molecules involved in the death process are identified, the aim being to come up with pharmaceutical medicines that will improve treatment.

Apart from working with in vitro cells, they are also experimenting with animals that reproduce some of the elements involved in neurodegenerative illnesses u
'"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
10-May-2007


Page: 1 2 3

Related medicine news :

1. Shark cartilage shows no benefit as a therapeutic agent for lung cancer
2. OCT1 required for therapeutic effects of diabetes drug Metformin
3. NeuroRx changes name to Neurotherapeutics
4. Olive Leaf report documents promising therapeutic interventions for 9-11 workers
5. T cells activated to fight HIV basis for dendritic cell therapeutic vaccine
6. Cerebrospinal fluid used to deliver therapeutics for Lou Gehrigs disease to brain
7. University to develop new therapeutics for cancer
8. Exubera: So far no evidence available of an additional therapeutic benefit
9. Nano-particles effective in killing cancer with one-two punch of chemotherapeutics
10. Researchers identify target for therapeutic drugs to fight most common adult brain cancer
11. Cedars-Sinai researchers demonstrate a new way to switch therapeutic genes on and off

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2018)... ... August 09, 2018 , ... ... monitoring with Smart-pill bottle and mobile applications, DoseSmart announced today the availability ... The DoseSmart medication management and medication adherence platform helps hospitals and health ...
(Date:8/7/2018)... (PRWEB) , ... August 07, 2018 , ... Sussex Vision ... with Blue Sky Vision. Michael Sussex, OD, founded the practice in Coldwater, and over ... practices with Matt Austin, OD, to offer comprehensive eye health services for patients of ...
(Date:8/3/2018)... , ... August 03, 2018 , ... On August 2, ... further proceedings. Mark Sadaka of Sadaka Associates, LLC has been litigating Zostavax ... argued before the Judicial Panel on Multidistrict Litigation for the thousands of people injured ...
(Date:8/2/2018)... ... August 02, 2018 , ... Allegheny Health Network ... connect clinicians inside and outside the network to vital patient imaging exams, saving ... AHN joins other leading hospital systems nationwide in using lifeIMAGE, which expands access ...
(Date:8/2/2018)... N.J. (PRWEB) , ... August 02, 2018 , ... ... 2018 will explore a range of topics in acute pain management. In The ... will discuss Michigan OPEN—the Opioid Prescribing Engagement Network—an innovative approach to the opioid ...
Breaking Medicine News(10 mins):
(Date:8/15/2018)... ... 2018 , ... Help Your Diabetes (HYD) is a Patent Pending, Internationally known, ... off their medication, working in conjunction with their primary physician. , The Founder/CEO, ... author of "Imagine Living Without Type 2 Diabetes. Dr. Hockings has given over 240 ...
(Date:8/15/2018)... ... August 15, 2018 , ... Schioppa Casters ... The newly designed Diamond Series features a caster specifically engineered for use ... antimicrobial compound injected into a thermoplastic resin during molding, Diamond Series casters provide ...
(Date:8/14/2018)... ANGELES (PRWEB) , ... August 14, 2018 , ... ... spearheading a unique fundraising event: The Saving Sophie Experience - A Journey To ... Hotel’s Tropicana Bar. Partygoers will have a meet and greet with Sophie herself, ...
Breaking Medicine Technology:
Cached News: